Latest Industry Insights

In this interview, Paul Withers from Eppendorf discusses the company’s latest addition to its pipetting lineup – the Research Pro Neo.

Discover how advanced drug delivery technologies are revolutionizing biotech, enabling safe, targeted cell therapy with fewer side effects.

Immuto Scientific’s structural surfaceomics platform reveals how wild-type proteins adopt disease-specific shapes that drive pathology. Immuto identifies previously invisible drug targets and designs conformation-selective therapies.

In this interview, Dr. Kelemen discusses the advantages of lipid-based delivery systems and their potential to expand the reach of CAR T-cell therapies into solid tumor indications.

In this interview, we explore how Sonrai is advancing reproducible science, enabling cross-disciplinary collaboration and shaping the future of AI-powered drug discovery.

Technology Networks asked a selection of start-up companies featured in the ELRIG Drug Discovery 2025 Breakthrough Zone how their technology could help realize the full capabilities of precision medicine.

Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.

Explore how biotech start-ups are using 3D models and automation to reduce animal testing, cut waste and improve drug discovery outcomes.

Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.

Discover how crowdfunding could help biotech startups and cell and gene therapy developers overcome funding barriers by engaging patients, physicians and everyday investors.